Nuclear Radiology: Page 79

Study: Lung scintigraphy tops CTA in PE
By AuntMinnieEurope.com staff writers
Lung scintigraphy may be more reliable than pulmonary CT angiography (CTA) for identifying or excluding pulmonary embolism (PE) in pregnant patients, according to a study published in the November issue of the American Journal of Roentgenology.
October 19, 2009
FDG-PET and CT useful in melanoma assessment
By Reuters Health
NEW YORK (Reuters Health), Oct 13 - In staging melanoma patients with palpable lymph nodes, fluorine-18 FDG-PET and CT are equivalent, but FDG-PET detects more metastatic sites, particularly bone and subcutaneous metastases, Dutch researchers report in the October 1 issue of the Journal of Clinical Oncology.
October 12, 2009
Reuterslogo
Dilon lands deal with Philips
By AuntMinnieEurope.com staff writers
Molecular breast imaging developer Dilon Diagnostics has signed a distribution agreement with Philips Healthcare covering markets in Europe and the Middle East.
October 11, 2009
FDG-PET uptake helps predict vascular events in cancer patients
By Wayne Forrest
German researchers have discovered that FDG uptake in major arteries is the "strongest predictor of a subsequent vascular event" in cancer patients, with severe calcification also indicating high risk, according to an article published in the October issue of the Journal of Nuclear Medicine.
October 8, 2009
2009 10 05 10 23 54 94 Vascular 01 Mol Ins Thumb
PET/CT helps speed lung cancer diagnosis
By AuntMinnieEurope.com staff writers
FDG-PET/CT can expedite the diagnosis of lung cancer in an outpatient setting, according to research from the Netherlands Cancer Institute in Amsterdam.
October 1, 2009
In vivo brain amyloid test predicts progression to Alzheimer's disease
By Reuters Health
NEW YORK (Reuters Health), Sep 24 - Increased brain amyloid load is associated with an increased risk of progression from mild cognitive impairment to Alzheimer's disease, according to a report in the September 8 issue of Neurology.
September 23, 2009
Reuterslogo
IBA, Aposense join forces
By AuntMinnieEurope.com staff writers
Radiopharmaceutical firm Ion Beam Applications (IBA) and molecular imaging and therapy developer Aposense have agreed to exclusively collaborate on the commercialization of Aposense's ML-10 PET tracer for molecular imaging of apoptosis.
September 21, 2009
Algeta, Bayer join forces
By AuntMinnieEurope.com staff writers
Therapeutic radiopharmaceutical developer Algeta has inked an $800 million agreement with Bayer for the development and commercialization of its Alpharadin alpha-emitting pharmaceutical for treating bone metastases.
September 7, 2009
SPECT/CT helps novice clinicians detect arthritic joints
By Wayne Forrest
SPECT/CT can help orthopedic surgeons and radiologists identify multiple arthritic joints in the feet and ankles and localize degenerative joint disease, according to a study published in the September issue of the British edition of the Journal of Bone and Joint Surgery.
September 7, 2009
Covidien retools, sells sleep unit
By AuntMinnieEurope.com staff writers
Healthcare technology firm Covidien announced a number of corporate changes this week, including the consolidation of its Imaging Solutions unit into another division and the sale of its sleep products business.
September 3, 2009
PET/CT may help detect recurring prostate cancer earlier
By AuntMinnieEurope.com staff writers
PET/CT scans with the imaging agent choline could detect recurring prostate cancer sooner than conventional imaging technologies in some patients who have had their prostates surgically removed.
September 1, 2009
IBA takes cyclotron order
By AuntMinnieEurope.com staff writers
Radiopharmaceutical firm Ion Beam Applications (IBA) has received an order for four Cyclone 18 cyclotron systems from Eczacıbaşı-Monrol Nuclear Products.
August 30, 2009
Previous Page
Page 79 of 90
Next Page